BlackRock’s Nautilus Biotechnolgy NAUT Stock Holding History
Bought
Maintained
Sold
Other funds holding NAUT
PA
ACM
CM
CFM
CA
BlackRock's NAUT Position: Q2 2026 in Review
BlackRock increased its Nautilus Biotechnolgy (NAUT) stake by 1,332% in Q2 2026, buying an estimated $6.6M and bringing the position to 2,687,226 shares worth $5.03M. The position accounts for ﹤0.01% of the portfolio, ranked #3923.
BlackRock first reported a position in NAUT in Q3 2020 and has held it in 24 quarters since. The position peaked at $13.9M in Q2 2023. 93 funds tracked by Wall St. Rank hold NAUT as of Q2 2026.
- BlackRock held 2,687,226 shares of Nautilus Biotechnolgy worth $5.03M as of Q2 2026.
- BlackRock bought 2,499,555 Nautilus Biotechnolgy shares in Q2 2026, an estimated $6.6M.
- Nautilus Biotechnolgy made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #3923 holding.
- BlackRock first reported a position in Nautilus Biotechnolgy in Q3 2020 and has held it in 24 quarters since.
- BlackRock's Nautilus Biotechnolgy position peaked at $13.9M in Q2 2023.
- 93 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q2 2026.
Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.